Characterization of polyurethane scaffold surface functionalization with diamines and heparin

Journal of Biomedical Materials Research - Part A

Volumn 101 A, Issue 4, 2013, Pages 919-922

  De Mulder, Eric L W ^a   Hannink, Gerjon ^a,b   Koens, Martin J W ^c   Löwik, Dennis W P M ^c   Verdonschot, Nico ^a,d   Buma, Pieter ^a  

^a Department of Orthopaedics   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Biomaterials; Heparin; Polyurethane; Surface treatment; Tissue engineering

Indexed keywords

3D POROUS SCAFFOLDS; CELL RECOGNITION SITES; FUNCTIONALIZATIONS; HEPARIN; HYDROPHILIC SURFACES; MECHANICAL STIFFNESS; POLYURETHANE SCAFFOLDS; SURFACE FUNCTIONALIZATION;

BEARINGS (MACHINE PARTS); BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMATERIALS; CONTACT ANGLE; CROSSLINKING; ELASTIC MODULI; POLYSACCHARIDES; POLYURETHANES; STIFFNESS; SURFACE TREATMENT; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

DIAMINE; HEPARIN; MOLECULAR SCAFFOLD; POLYURETHAN; URETHAN;

AMINOLYSIS; ARTICLE; CHEMICAL PARAMETERS; CONTACT ANGLE; CROSS LINKING; HYDROPHILICITY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MECHANICAL STIFFNESS; SURFACE PROPERTY; TISSUE ENGINEERING; YOUNG MODULUS;

DIAMINES; ELASTIC MODULUS; HEPARIN; HOT TEMPERATURE; POLYURETHANES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84876197087     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34389     Document Type: Article

References (20)

1. Marois Y, Guidoin R. Biocompatibility of Polyurethanes. In: Vermette P, Griesser HJ, Laroche G, Guidoin R, editors. Biomedical Applications of Polyurethanes. Georgetown: Landes Bioscience; 2001. p 77-96.
2. Hsieh CH, Kuo WT, Huang YC, Huang YY. High-efficiency cell seeding method by relatively hydrophobic culture strategy. J Biomed Mater Res B Appl Biomater 2011;98:38-46.
3. Zhu Y, Gao C, Liu X, Shen J. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecule immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules 2002;3:1312-1319.
4. Chang KY, Cheng LW, Ho GH, Huang YP, Lee YD. Fabrication and characterization of poly(gamma-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering. Acta Biomater 2009;5:1937-1947.
5. Zhu Y, Chian KS, Chan-Park MB, Mhaisalkar PS, Ratner BD. Protein bonding on biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue engineering. Biomaterials 2006; 27:68-78.
6. Zhu Y, Gao C, Liu X, He T, Shen J. Immobilization of biomacromolecules onto aminolyzed poly(L-lactic acid) toward acceleration of endothelium regeneration. Tissue Eng 2004;10:53-61.
7. Stringer SE, Gallagher JT. Heparan sulphate. Int J Biochem Cell Biol 1997;29:709-714.
8. Gunja NJ, Athanasiou KA. Passage and reversal effects on gene expression of bovine meniscal fibrochondrocytes. Arthritis Res Ther 2007;9:R93.
9. van Minnen B, van Leeuwen MB, Stegenga B, Zuidema J, Hissink CE, van Kooten TG, Bos RR. Short-term in vitro and in vivo biocompatibility of a biodegradable polyurethane foam based on 1,4-butanediisocyanate. J Mater Sci Mater Med 2005;16:221-227.
10. Chang KY, Hung LH, Chu IM, Ko CS, Lee YD. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering. J Biomed Mater Res A 2010; 92:712-723.
11. Pieper JS, Hafmans T, Veerkamp JH, van Kuppevelt TH. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 2000; 21:581-593.
12. Nuininga JE, Koens MJ, Tiemessen DM, Oosterwijk E, Daamen WF, Geutjes PJ, van Kuppevelt TH, Feitz WF. Urethral reconstruction of critical defects in rabbits using molecularly defined tubular type I collagen biomatrices: key issues in growth factor addition. Tissue Eng Part A 2010;16:3319-3328.
13. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 1998;273:12960-12966.
14. Das T, Sharma PK, Krom BP, van der Mei HC, Busscher HJ. Role of eDNA on the adhesion forces between Streptococcus mutans and substratum surfaces: influence of ionic strength and substratum hydrophobicity. Langmuir 2011;27:10113-10118.
15. Singh S, Wu BM, Dunn JC. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Biomaterials 2011;32:2059-2069.
16. Talukdar S, Nguyen QT, Chen AC, Sah RL, Kundu SC. Effect of initial cell seeding density on 3D-engineered silk fibroin scaffolds for articular cartilage tissue engineering. Biomaterials 2011;32: 8927-8937.
17. de Mulder EL, Hannink G, Giele M, Verdonschot N, Buma P. Proliferation of meniscal fibrochondrocytes cultured on a new polyurethane scaffold is stimulated by TGF-ss. J Biomater Appl. Forthcoming.
18. McCaffrey TA, Falcone DJ, Du B. Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparinbinding regions and isolation of heparins with varying affinity for TGF-beta 1. J Cell Physiol 1992;152:430-440.
19. Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J Biol Chem 2004;279:12346-12354.
20. van Tienen TG, Heijkants RG, Buma P, de Groot JH, Pennings AJ, Veth RP. Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. Biomaterials 2002;23:1731-1738.